BG64560B1 - Бензазепинови производни, лекарствени средства, които ги съдържат, и тяхното приложение за получаването на лекарства - Google Patents
Бензазепинови производни, лекарствени средства, които ги съдържат, и тяхното приложение за получаването на лекарства Download PDFInfo
- Publication number
- BG64560B1 BG64560B1 BG102836A BG10283698A BG64560B1 BG 64560 B1 BG64560 B1 BG 64560B1 BG 102836 A BG102836 A BG 102836A BG 10283698 A BG10283698 A BG 10283698A BG 64560 B1 BG64560 B1 BG 64560B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- alkyl
- group
- hydrogen
- substituted
- dream
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0071696A AT403803B (de) | 1996-04-19 | 1996-04-19 | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
Publications (2)
Publication Number | Publication Date |
---|---|
BG102836A BG102836A (en) | 1999-09-30 |
BG64560B1 true BG64560B1 (bg) | 2005-07-29 |
Family
ID=3497932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG102836A BG64560B1 (bg) | 1996-04-19 | 1998-10-12 | Бензазепинови производни, лекарствени средства, които ги съдържат, и тяхното приложение за получаването на лекарства |
Country Status (12)
Country | Link |
---|---|
US (2) | US6638925B2 (fr) |
EP (2) | EP1757608A1 (fr) |
AT (1) | AT403803B (fr) |
AU (1) | AU2498597A (fr) |
BG (1) | BG64560B1 (fr) |
CZ (1) | CZ300211B6 (fr) |
IS (1) | IS4839A (fr) |
NO (1) | NO324211B1 (fr) |
PL (2) | PL189834B1 (fr) |
RO (1) | RO120136B1 (fr) |
TW (1) | TWI224595B (fr) |
WO (1) | WO1997040049A1 (fr) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT403803B (de) * | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
US7214686B2 (en) * | 1997-06-30 | 2007-05-08 | Targacept, Inc. | Pharmaceutical compositions and methods for effecting dopamine release |
WO2000032199A1 (fr) * | 1998-12-01 | 2000-06-08 | Sanochemia Pharmazeutika Aktiengesellschaft | Utilisation de galanthamine et de derives de galanthamine en cas de lesions cerebrales fonctionnelles aigues |
WO2000066586A1 (fr) * | 1999-05-04 | 2000-11-09 | Neurosearch A/S | Diazabicycloalcanes heteroaryles, leur preparation et leur utilisation |
JP2003529602A (ja) * | 2000-03-31 | 2003-10-07 | ザノヒェミア・ファルマツォイティカ・アーゲー | ガランタミンの新規誘導体および類似体 |
KR100768245B1 (ko) * | 2000-03-31 | 2007-10-17 | 자노케미아 파마조이티카 악티엔게젤샤프트 | 신규한 갈란타민 유도체 및 유사체 |
US6852721B2 (en) | 2000-05-25 | 2005-02-08 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
US6440970B1 (en) * | 2000-05-25 | 2002-08-27 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
DE60108639T2 (de) | 2000-07-04 | 2005-07-07 | Neurosearch A/S | Aryl- und heteroaryldiazabicycloalkane, deren zubereitung und verwendung |
EP1326867A2 (fr) * | 2000-10-19 | 2003-07-16 | Pfizer Products Inc. | Derives de piperazine pontes |
US20040029894A1 (en) * | 2000-12-07 | 2004-02-12 | Nobuya Matsuoka | Nootropic effect enhancer |
WO2002094799A2 (fr) * | 2001-05-22 | 2002-11-28 | Neurogen Corporation | Ligands recepteurs de l'hormone de concentration de la melanine: analogues de 1-benzyl-4-aryl piperazine substituee |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
JP4721386B2 (ja) * | 2001-07-10 | 2011-07-13 | 第一三共株式会社 | 新規ガランタミン類縁体 |
DE10134038A1 (de) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit |
EA009789B1 (ru) | 2002-07-05 | 2008-04-28 | Таргасепт, Инк. | N-арилдиазаспирациклические соединения и способы их получения и применения |
WO2004009775A2 (fr) | 2002-07-19 | 2004-01-29 | Targacept, Inc. | Methodes et compositions associees a des sous-unites de recepteurs nicotiniques chimeriques |
US7098331B2 (en) * | 2003-03-05 | 2006-08-29 | Targacept, Inc. | Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
US20070054940A1 (en) * | 2003-09-19 | 2007-03-08 | Eisai Co., Ltd. | Remedy for down's syndrome |
AT414125B (de) * | 2003-09-29 | 2006-09-15 | Sanochemia Pharmazeutika Ag | Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln |
DK1678172T3 (da) * | 2003-10-15 | 2010-04-06 | Targacept Inc | Azabicykliske forbindelser til lindring af smerte og behandling af sygdomme i centralnervesystemet |
AT500143A1 (de) * | 2004-04-22 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung |
AU2005247405A1 (en) * | 2004-05-17 | 2005-12-08 | Acadia Pharmaceuticals Inc. | Androgen receptor modulators and method of treating disease using the same |
US20070004679A1 (en) * | 2004-05-17 | 2007-01-04 | Nathalie Schlienger | Androgen receptor modulators and methods of treating disease using the same |
US20050261278A1 (en) * | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
AU2005287037A1 (en) * | 2004-09-20 | 2006-03-30 | Targacept, Inc. | Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
DK1815028T3 (da) | 2004-11-03 | 2012-01-30 | Iris Molecular Diagnostics Inc | Mikrobobler til affinitetsseparation |
DK1842226T3 (da) | 2004-11-03 | 2010-10-18 | Iris Molecular Diagnostics Inc | Homogen analytpåvisning |
UA88792C2 (ru) * | 2004-11-10 | 2009-11-25 | Таргасепт, Інк. | Гидроксибензоатные соли метаникотиновых соединений |
US7459469B2 (en) * | 2004-11-10 | 2008-12-02 | Targacept, Inc. | Hydroxybenzoate salts of metanicotine compounds |
ITMI20042413A1 (it) * | 2004-12-17 | 2005-03-17 | Indena Spa | Processo per la preparazione di galantamina bromidrato |
WO2006072818A2 (fr) * | 2005-01-04 | 2006-07-13 | Emcure Pharmaceuticals Limited | Procede pour preparer de la benzazepine |
US20060173037A1 (en) * | 2005-01-10 | 2006-08-03 | Nathalie Schlienger | Aminophenyl derivatives as selective androgen receptor modulators |
AU2006205066B2 (en) * | 2005-01-10 | 2012-05-17 | Acadia Pharmaceuticals Inc. | Aminophenyl derivatives as selective androgen receptor modulators |
US20100168081A1 (en) * | 2005-08-11 | 2010-07-01 | Adriana Di Polo | Galantamine as a neuroprotective drug for retinal ganglion cells |
KR20080035649A (ko) * | 2005-08-22 | 2008-04-23 | 타가셉트 인코포레이티드 | 헤테로아릴로 치환된 디아자트리시클로알칸, 그 제조방법및 용도 |
EP1777222A1 (fr) * | 2005-09-22 | 2007-04-25 | Galantos Pharma GmbH | Inhibiteurs de la cholinesterase avec une perméabilité améliorée de la barrière ématoencéphalique pour le traitement de troubles cognitifs |
US20090253654A1 (en) | 2005-09-22 | 2009-10-08 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
US20070213318A1 (en) * | 2006-03-07 | 2007-09-13 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
AU2006326540A1 (en) | 2005-12-14 | 2007-06-21 | Amgen Inc. | Diaza heterocyclic sulfonamide derivatives and their uses |
US8672732B2 (en) * | 2006-01-19 | 2014-03-18 | Schneider Electric It Corporation | Cooling system and method |
CN100384850C (zh) * | 2006-04-14 | 2008-04-30 | 浙江大学 | 加兰他敏衍生物及制备方法和用途 |
TWI389889B (zh) * | 2006-05-09 | 2013-03-21 | Targacept Inc | (2s)-(4e)-n-甲基-5-〔3-(5-異丙氧基吡啶)基〕-4-戊烯-2-胺之新穎多晶型 |
WO2007134038A2 (fr) * | 2006-05-09 | 2007-11-22 | Astrazeneca Ab | Nouvelles formes de sel de (2s)-(4e)-méthyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine |
NZ573129A (en) * | 2006-06-28 | 2011-06-30 | Amgen Inc | Piperazine acetic acid glycine transporter-1 inhibitors |
CL2007002684A1 (es) * | 2006-09-15 | 2008-06-27 | Astrazeneca Ab Targacept Inc | Combinacion que comprende un antipsicotico y (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina; composicion farmaceutica que la comprende; kit farmaceutico; y uso para tratar perjuicio cognitivo y/o trastorno psicoticos. |
WO2008091592A1 (fr) * | 2007-01-22 | 2008-07-31 | Targacept, Inc. | Administration intranasale, buccale et sublinguale d'analogues de métanicotine |
EP2182932A2 (fr) * | 2007-07-31 | 2010-05-12 | Targacept Inc. | Administration transdermique de (2s)-(4e)-n-méthyl-5-(3-(5-isopropoxypyridin)yl)-4-pentén-2-amine |
CA2701126A1 (fr) | 2007-10-01 | 2009-04-09 | Comentis, Inc. | Derives de quinuclidine substitue en position 4, methodes de production et usages pharmaceutiques associes |
JP5504253B2 (ja) | 2008-04-14 | 2014-05-28 | ニューロダイン ライフ サイエンス インコーポレイテッド | ヒトの脳疾患の治療のためのプロドラッグとしてのガランタミン誘導体 |
MX2012006484A (es) | 2009-12-07 | 2012-08-01 | Targacept Inc | 3,6-diazabiciclo [3.1.1] heptanos como ligandos de receptores nicotinicos neuronales de acetilcolina. |
CN103180277A (zh) | 2010-05-20 | 2013-06-26 | 塔格塞普特股份有限公司 | 制备芳基取代的烯属胺的新方法 |
WO2013160728A1 (fr) | 2012-04-26 | 2013-10-31 | Alma Mater Studiorum - Universita' Di Bologna | Composés à double ciblage pour le traitement de la maladie d'alzheimer |
CN104447767B (zh) * | 2013-09-24 | 2018-08-03 | 连云港金康医药科技有限公司 | 氮杂双环[3,2,1]辛烷衍生物及其应用 |
WO2016007630A1 (fr) | 2014-07-11 | 2016-01-14 | Alpharmagen, Llc | Composés de quinuclidine pour moduler l'activité du récepteur nicotinique alpha7 de l'acétylcholine |
WO2017189834A1 (fr) * | 2016-04-29 | 2017-11-02 | New Mexico Tech Research Foundation | Méthodes pour le traitement d'un cancer résistant |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0236684A2 (fr) * | 1986-01-15 | 1987-09-16 | Synaptech, Inc. | Galanthamine ou ses analogues pour le traitement de la maladie d'Alzheimer |
WO1995027715A2 (fr) * | 1994-04-08 | 1995-10-19 | Ciba-Geigy Corporation | Procede de production a haut rendement de galanthamine (-) tres pure essentiellement exempte d'epigalanthamine |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947445A (en) | 1974-05-09 | 1976-03-30 | Stanford Research Institute | Diazabicyclooctanes and diazabicycloheptanes |
KR100195399B1 (ko) | 1987-05-04 | 1999-06-15 | 보니데이비스 | 알쯔하이머 병 치료용 의약 |
GB8800694D0 (en) | 1988-01-13 | 1988-02-10 | Pfizer Ltd | Antiarrhythmic agents |
NL8800350A (nl) * | 1988-02-12 | 1989-09-01 | Stichting Biomedical Research | Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen. |
US4954502A (en) * | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
CA2012681A1 (fr) | 1989-03-31 | 1990-09-30 | Masayasu Okuhira | Derives de la quinolone, procedes de preparation et agents antibacteriens les renfermant |
US5036153A (en) | 1989-05-11 | 1991-07-30 | Braish Tamim F | Preparation of 2,5-diazabicyclo[2.2.1]heptanes and intermediates |
US4994460A (en) | 1989-06-01 | 1991-02-19 | Bristol-Myers Squibb Co. | Agents for treatment of brain ischemia |
MX9203454A (es) | 1989-12-28 | 1992-08-01 | Upjohn Co | Compuestos anti sida diaromaticos substituidos. |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
HU213097B (en) | 1991-05-14 | 1997-02-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing phenylpiperazines |
US5153193A (en) | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
US6323196B1 (en) | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6316439B1 (en) | 1993-10-15 | 2001-11-13 | Aventis Pharamaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6323195B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
JP4187786B2 (ja) * | 1994-10-21 | 2008-11-26 | ザノヒェミア・ファルマツォイティカ・アー・ゲー | 4a,5,9,10,11,12−ヘキサヒドロ−6H−ベンゾフロ[3a,3,2−ef][2]ベンズアゼピン誘導体の製造方法 |
AT401058B (de) | 1994-10-21 | 1996-06-25 | Waldheim Pharmazeutika Gmbh | Verfahren zum herstellen von derivaten des 4a,5, 9,10,11,12,-hexahydro-6h-benzofuro(3a,-3,2-ef) (2)benzazepins |
US6407229B1 (en) | 1994-10-21 | 2002-06-18 | Sanochemia Pharmazeutika Ag | Processes for the preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro-[3a,3,2-ef][2] benzazapine |
GB9519268D0 (en) | 1995-09-21 | 1995-11-22 | Chiroscience Ltd | Preparation of alkaloids |
AT403803B (de) | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
WO2000032199A1 (fr) | 1998-12-01 | 2000-06-08 | Sanochemia Pharmazeutika Aktiengesellschaft | Utilisation de galanthamine et de derives de galanthamine en cas de lesions cerebrales fonctionnelles aigues |
AT414125B (de) | 2003-09-29 | 2006-09-15 | Sanochemia Pharmazeutika Ag | Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln |
-
1996
- 1996-04-19 AT AT0071696A patent/AT403803B/de not_active IP Right Cessation
-
1997
- 1997-04-21 PL PL97329411A patent/PL189834B1/pl not_active IP Right Cessation
- 1997-04-21 CZ CZ0332498A patent/CZ300211B6/cs not_active IP Right Cessation
- 1997-04-21 WO PCT/AT1997/000074 patent/WO1997040049A1/fr not_active Application Discontinuation
- 1997-04-21 RO RO98-01487A patent/RO120136B1/ro unknown
- 1997-04-21 US US09/242,339 patent/US6638925B2/en not_active Expired - Fee Related
- 1997-04-21 EP EP06025028A patent/EP1757608A1/fr not_active Withdrawn
- 1997-04-21 AU AU24985/97A patent/AU2498597A/en not_active Abandoned
- 1997-04-21 PL PL97361697A patent/PL190032B1/pl not_active IP Right Cessation
- 1997-04-21 EP EP97916263A patent/EP0897387A1/fr not_active Ceased
- 1997-05-09 TW TW086106195A patent/TWI224595B/zh not_active IP Right Cessation
-
1998
- 1998-08-28 IS IS4839A patent/IS4839A/is unknown
- 1998-10-12 BG BG102836A patent/BG64560B1/bg unknown
- 1998-10-16 NO NO19984852A patent/NO324211B1/no not_active IP Right Cessation
-
2003
- 2003-08-26 US US10/647,283 patent/US7101890B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0236684A2 (fr) * | 1986-01-15 | 1987-09-16 | Synaptech, Inc. | Galanthamine ou ses analogues pour le traitement de la maladie d'Alzheimer |
WO1995027715A2 (fr) * | 1994-04-08 | 1995-10-19 | Ciba-Geigy Corporation | Procede de production a haut rendement de galanthamine (-) tres pure essentiellement exempte d'epigalanthamine |
Also Published As
Publication number | Publication date |
---|---|
US20040067974A1 (en) | 2004-04-08 |
CZ300211B6 (cs) | 2009-03-18 |
PL189834B1 (pl) | 2005-09-30 |
RO120136B1 (ro) | 2005-09-30 |
NO984852D0 (no) | 1998-10-16 |
US20030092700A1 (en) | 2003-05-15 |
US7101890B2 (en) | 2006-09-05 |
NO324211B1 (no) | 2007-09-10 |
EP0897387A1 (fr) | 1999-02-24 |
AT403803B (de) | 1998-05-25 |
BG102836A (en) | 1999-09-30 |
WO1997040049A1 (fr) | 1997-10-30 |
ATA71696A (de) | 1997-10-15 |
NO984852L (no) | 1998-11-16 |
IS4839A (is) | 1998-08-28 |
AU2498597A (en) | 1997-11-12 |
CZ332498A3 (cs) | 1999-05-12 |
PL190032B1 (pl) | 2005-10-31 |
PL329411A1 (en) | 1999-03-29 |
US6638925B2 (en) | 2003-10-28 |
EP1757608A1 (fr) | 2007-02-28 |
TWI224595B (en) | 2004-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG64560B1 (bg) | Бензазепинови производни, лекарствени средства, които ги съдържат, и тяхното приложение за получаването на лекарства | |
US6774132B1 (en) | Spirooxindole derivatives that act as analgesics | |
RU2104269C1 (ru) | Производные изоиндолона или их соли с кислотами в качестве промежуточных соенинений для синтеза биологически активных соединений - пергидроизоиндолонов | |
JPS62201882A (ja) | イソフラボン誘導体 | |
US20090215746A1 (en) | Substituted pyrazolo[1,5-a]pyrimidines as calcium receptor modulating agents | |
RU2146258C1 (ru) | Способы получения производных 4а,5,9,10,11,12-гексагидро-6н-бензофуро(3а,3,2-ef)(2)бензазепина и промежуточные соединения | |
CZ410791A3 (en) | Amides of thieno-triazolo-1,4-diazepino-2-carboxylic acid, process of their preparation and pharmaceutical preparation based thereon | |
EP0091241A2 (fr) | Dérivés condensés de pyrrolinone, et leur préparation | |
AU640300B2 (en) | Pharmacologically active substituted oxybenzamides | |
BG65134B1 (bg) | Производни и аналози на галантамин | |
US3845060A (en) | 1-(1-(2,3-dihydro-2-benzofuryl)-alkyl)-4-aminohexahydroisonicotinic acid amides or nitriles | |
KR20060111518A (ko) | 신규 화합물 | |
EP0174858B1 (fr) | Dérivés de l'isoindolinone, leur préparation et leur utilisation | |
US5075317A (en) | Spirofurane derivatives | |
Trauner | New ventures in the construction of complex heterocycles: synthesis of morphine and hasubanan alkaloids | |
AU597083B2 (en) | 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties | |
FI72514C (fi) | Foerfarande foer framstaellning av nya antiallergiska bensoxazol- och bensotiazol-2-karboxylsyraestrar. | |
US4965259A (en) | Dioxazocine derivatives compositions and methods containing them having antidepressive, spasmolytic, anticonvulsive, and antiarrhythmic properties | |
US4591587A (en) | Cyclopropyl pyridine compounds useful as calcium channel blockers | |
FI79322C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-fenyl-isoxazolo/4,5-c/kinolin-3-oner. | |
JPS63170356A (ja) | アニリン誘導体及びその製造法 | |
US4318909A (en) | Benzoxazocines | |
US4235901A (en) | 1-Hydroxyalkanamine pyrano(3,4-b)indole compositions and use thereof | |
US3857854A (en) | 6-phenyl-1h,4h-{8 1,2,4{9 oxadiazalo{8 4,3-2{9 {8 1,4{9 benzodiazepin-1-ones | |
US4626522A (en) | Benzoxazocines intermediates |